MetLife Investment Management’s Pediatrix Medical MD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.04M | Sell |
48,624
-502
| -1% | -$10.4K | 0.01% | 1375 |
|
|
2025
Q4 | $1.05M | Sell |
49,126
-3,361
| -6% | -$68.9K | 0.01% | 1398 |
|
|
2025
Q3 | $879K | Hold |
52,487
| – | – | ﹤0.01% | 1521 |
|
|
2025
Q2 | $753K | Hold |
52,487
| – | – | ﹤0.01% | 1462 |
|
|
2025
Q1 | $761K | Sell |
52,487
-1,065
| -2% | -$15.1K | ﹤0.01% | 1497 |
|
|
2024
Q4 | $703K | Buy |
53,552
+3,419
| +7% | +$47.2K | ﹤0.01% | 1604 |
|
|
2024
Q3 | $581K | Hold |
50,133
| – | – | ﹤0.01% | 1701 |
|
|
2024
Q2 | $379K | Buy |
50,133
+4,982
| +11% | +$41.2K | ﹤0.01% | 1879 |
|
|
2024
Q1 | $453K | Hold |
45,151
| – | – | ﹤0.01% | 1731 |
|
|
2023
Q4 | $420K | Hold |
45,151
| – | – | ﹤0.01% | 1795 |
|
|
2023
Q3 | $574K | Hold |
45,151
| – | – | ﹤0.01% | 1547 |
|
|
2023
Q2 | $642K | Hold |
45,151
| – | – | ﹤0.01% | 1532 |
|
|
2023
Q1 | $673K | Hold |
45,151
| – | – | ﹤0.01% | 1458 |
|
|
2022
Q4 | $671K | Hold |
45,151
| – | – | 0.01% | 1455 |
|
|
2022
Q3 | $745K | Buy |
45,151
+1,040
| +2% | +$20.9K | 0.01% | 1355 |
|
|
2022
Q2 | $927K | Buy |
44,111
+2,093
| +5% | +$42.7K | 0.01% | 1248 |
|
|
2022
Q1 | $987K | Buy |
42,018
+15,170
| +57% | +$371K | 0.01% | 1335 |
|
|
2021
Q4 | $731K | Hold |
26,848
| – | – | 0.01% | 1289 |
|
|
2021
Q3 | $763K | Hold |
26,848
| – | – | 0.01% | 1271 |
|
|
2021
Q2 | $809K | Hold |
26,848
| – | – | 0.01% | 1292 |
|
|
2021
Q1 | $684K | Sell |
26,848
-5,176
| -16% | -$133K | 0.01% | 1346 |
|
|
2020
Q4 | $786K | Sell |
32,024
-48,930
| -60% | -$919K | 0.01% | 1242 |
|
|
2020
Q3 | $1.32M | Sell |
80,954
-6,957
| -8% | -$129K | 0.01% | 910 |
|
|
2020
Q2 | $1.5M | Buy |
87,911
+39,523
| +82% | +$586K | 0.02% | 846 |
|
|
2020
Q1 | $563K | Hold |
48,388
| – | – | 0.01% | 1150 |
|
|
2019
Q4 | $1.34M | Sell |
48,388
-592
| -1% | -$14.8K | 0.01% | 957 |
|
|
2019
Q3 | $1.11M | Sell |
48,980
-2,290
| -4% | -$52.2K | 0.01% | 1017 |
|
|
2019
Q2 | $1.29M | Sell |
51,270
-2,323
| -4% | -$62.4K | 0.01% | 999 |
|
|
2019
Q1 | $1.46M | Sell |
53,593
-929
| -2% | -$31.1K | 0.02% | 934 |
|
|
2018
Q4 | $1.8M | Sell |
54,522
-2,699
| -5% | -$109K | 0.02% | 792 |
|
|
2018
Q3 | $2.67M | Sell |
57,221
-2,169
| -4% | -$99.6K | 0.03% | 730 |
|
|
2018
Q2 | $2.57M | Buy |
59,390
+856
| +1% | +$41K | 0.03% | 698 |
|
|
2018
Q1 | $3.26M | Sell |
58,534
-722
| -1% | -$39.6K | 0.04% | 560 |
|
|
2017
Q4 | $3.17M | Buy |
+59,256
| New | +$2.8M | 0.04% | 609 |
|
Other funds holding MD
VPM
VCM
WA
MetLife Investment Management's MD Position: Q1 2026 in Review
MetLife Investment Management reduced its Pediatrix Medical (MD) stake by 1% in Q1 2026, selling an estimated $10.4K and leaving 48,624 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #1375.
MetLife Investment Management first reported a position in MD in Q4 2017 and has held it in 34 quarters since. The position peaked at $3.26M in Q1 2018. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.
- MetLife Investment Management held 48,624 shares of Pediatrix Medical worth $1.04M as of Q1 2026.
- MetLife Investment Management sold 502 Pediatrix Medical shares in Q1 2026, an estimated $10.4K.
- Pediatrix Medical made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1375 holding.
- MetLife Investment Management first reported a position in Pediatrix Medical in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Pediatrix Medical position peaked at $3.26M in Q1 2018.
- 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.